http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5290920-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e06d8df5ecb58e082a70a2bd8c474836
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-12
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-20
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-485
filingDate 1992-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1994-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_661525697ab282da595a2d118ab586f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_beeec331728bf014663d86dc48ed52cf
publicationDate 1994-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5290920-A
titleOfInvention Method of purifying human epidermal growth factor
abstract Human epidermal growth factor is provided in an ultrapure form characterized by the absence of protein contaminants detectable by capillary electrophoresis analysis. A method for obtaining such ultrapure human epidermal growth factor includes fractionation of a human epidermal growth factor preparation by reversed phase high performance liquid chromatography in the presence of a cationic ion-pairing agent.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004037818-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008076788-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2508294-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006234373-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021025877-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112250753-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100488287-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004209816-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002182651-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7179655-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008076788-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007066520-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009041731-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6320026-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011018745-A1
priorityDate 1992-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0352839-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4717717-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0205051-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0357391-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0240031-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9115228-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129828910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226551289
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129569275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9777
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235

Total number of triples: 55.